Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Spain, United Kingdom, United States (Lazertinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Duarte, California
  • +8 more
Jan 31, 2023

NSCLC Trial in Worldwide (TAK-788)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +56 more
Jan 23, 2023

NSCLC Trial in Worldwide (Sasanlimab Prefilled syringe, Encorafenib, Binimetinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sasanlimab Prefilled syringe
  • +5 more
  • Duarte, California
  • +96 more
Jan 18, 2023

NSCLC Trial in Worldwide (CC-486, Pembrolizumab, Placebo)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Glendale, Arizona
  • +33 more
Jan 12, 2023

NSCLC Trial in Worldwide (AZD7789)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Atlanta, Georgia
  • +8 more
Jan 12, 2023

Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)

Active, not recruiting
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • BI 754111
  • BI 754091
  • Miami, Florida
  • +14 more
Jan 9, 2023

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting
  • Malignant Melanoma
  • +4 more
  • Duarte, California
  • +71 more
Dec 29, 2022

NSCLC Trial in Worldwide (Selpercatinib, Placebo)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Santa Monica, California
  • +206 more
Dec 27, 2022

Advanced Solid Tumor, Urinary Bladder Tumor, Pancreatic Tumors Trial in Worldwide (BT8009, Nivolumab)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Denver, Colorado
  • +20 more
Nov 22, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Tumors, NSCLC, Pancreatic Tumors Trial in Worldwide (V941, Pembrolizumab)

Completed
  • Neoplasms
  • +3 more
  • V941
  • Pembrolizumab
  • Gilbert, Arizona
  • +25 more
Sep 5, 2022

NSCLC Trial in Worldwide (Amivantamab, Osimertinib, Lazertinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Goodyear, Arizona
  • +266 more
Aug 17, 2022

NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Pemetrexed)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Phoenix, Arizona
  • +303 more
Aug 17, 2022

Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

Recruiting
  • Uterine Neoplasms
  • +5 more
  • Goodyear, Arizona
  • +63 more
Aug 15, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

Recruiting
  • Ovarian Neoplasms
  • +9 more
  • Aurora, Colorado
  • +6 more
Aug 15, 2022

NSCLC Trial in Belgium, France, United States (Cisplatin, Carboplatin, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fountain Valley, California
  • +18 more
Aug 10, 2022

Lung Tumors, NSCLC, Lung Diseases Trial in Worldwide (CK-101)

Completed
  • Lung Neoplasms
  • +3 more
  • Sarasota, Florida
  • +19 more
Jul 25, 2022

NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Los Angeles, California
  • +21 more
Jul 22, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

NSCLC Trial in Worldwide (Lorlatinib, Crizotinib)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Altamonte Springs, Florida
  • +164 more
May 27, 2022

NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Mobile, Alabama
  • +14 more
May 12, 2022

NSCLC, Triple Negative Breast Tumors, Squamous Cell Carcinoma of Head and Neck Trial in United States (Pembrolizumab, TAK-676,

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • West Hollywood, California
  • +5 more
Mar 17, 2022

Tumors, Tumor Metastasis, NSCLC Trial in Sarasota, Nashville, Milwaukee (BI 891065, BI 754091)

Terminated
  • Neoplasms
  • +2 more
  • BI 891065
  • BI 754091
  • Sarasota, Florida
  • +2 more
Oct 7, 2021

Metastatic Pancreatic Cancer, Colorectal Cancer, Esophageal Tumors Trial in Japan, United States (TAK-931)

Completed
Has Results
  • Metastatic Pancreatic Cancer
  • +3 more
  • Denver, Colorado
  • +9 more
Aug 24, 2021

NSCLC Trial in Worldwide (Avelumab, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Tuscaloosa, Alabama
  • +259 more
Jul 20, 2020